Literature DB >> 17999941

Sepsis is associated with an upregulation of functional beta3 adrenoceptors in the myocardium.

S Moniotte1, C Belge, B Sekkali, P B Massion, B Rozec, C Dessy, J-L Balligand.   

Abstract

OBJECTIVE: To analyze the implication of the beta3-adrenoceptor (beta3-AR) pathway in human septic myocardium and a murine model of sepsis, a condition associated with myocardial depression. METHODS AND
RESULTS: beta3-AR and eNOS protein abundance were increased (332+/-66.4% and 218+/-39.3; P<0.05) in hearts from septic patients. The effect of BRL37344, a beta3-AR-preferential agonist, was analyzed by videomicroscopy on the contractility of neonatal mouse ventricular myocytes (NMVM) incubated with conditioned medium from LPS-stimulated cultured macrophages (Mc-LPS+ medium). Stimulation of untreated NMVM with BRL37344 dose-dependently decreased the amplitude of contractile shortening (P<0.05). This response was abolished by L-NAME (NOS inhibitor). Incubation in Mc-LPS+ medium potentiated the depressing effect of BRL37344 (P<0.05) as well as of SR58611A (P<0.05) in wild-type myocytes. Importantly, the contractile depression was abrogated in cardiomyocytes from beta3-AR KO mice.
CONCLUSIONS: beta3-AR are upregulated during sepsis in the human myocardium and by cytokines in murine cardiomyocytes, where they mediate an increased negative inotropic response to beta3 agonists. Activation of the beta3-AR pathway by catecholamines may contribute to the myocardial dysfunction in sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999941     DOI: 10.1016/j.ejheart.2007.10.006

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  21 in total

Review 1.  Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies.

Authors:  Chantal Gauthier; Bertrand Rozec; Boris Manoury; Jean-Luc Balligand
Journal:  Curr Heart Fail Rep       Date:  2011-09

2.  Up-regulation and functional effect of cardiac β3-adrenoreceptors in alcoholic monkeys.

Authors:  Heng-Jie Cheng; Kathleen A Grant; Qing-Hua Han; James B Daunais; David P Friedman; Satoshi Masutani; William C Little; Che-Ping Cheng
Journal:  Alcohol Clin Exp Res       Date:  2010-05-12       Impact factor: 3.455

3.  Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.

Authors:  Bat-Erdene Myagmar; James M Flynn; Patrick M Cowley; Philip M Swigart; Megan D Montgomery; Kevin Thai; Divya Nair; Rumita Gupta; David X Deng; Chihiro Hosoda; Simon Melov; Anthony J Baker; Paul C Simpson
Journal:  Circ Res       Date:  2017-02-20       Impact factor: 17.367

4.  Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.

Authors:  Valentina Vasina; Ferdinando Giannone; Marco Domenicali; Rocco Latorre; Annalisa Berzigotti; Paolo Caraceni; Marco Zoli; Fabrizio De Ponti; Mauro Bernardi
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

5.  The Trend of β3-Adrenergic Receptor in the Development of Septic Myocardial Depression: A Lipopolysaccharide-Induced Rat Septic Shock Model.

Authors:  Ni Yang; Xiao-Lu Shi; Bing-Lun Zhang; Jian Rong; Tie-Ning Zhang; Wei Xu; Chun-Feng Liu
Journal:  Cardiology       Date:  2018-03-22       Impact factor: 1.869

6.  Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.

Authors:  An L Moens; Jordan S Leyton-Mange; Xiaolin Niu; Ronghua Yang; Oscar Cingolani; Elisabeth K Arkenbout; Hunter C Champion; Djahida Bedja; Kathleen L Gabrielson; Juan Chen; Yong Xia; Ashley B Hale; Keith M Channon; Marc K Halushka; Norman Barker; Floris L Wuyts; Pawel M Kaminski; Michael S Wolin; David A Kass; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

7.  Cross-regulation between beta 1- and beta 3-adrenoceptors following chronic beta-adrenergic stimulation in neonatal rat cardiomyocytes.

Authors:  Christoph Ufer; Renée Germack
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

8.  Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation.

Authors:  V Montiel; E Leon Gomez; C Bouzin; H Esfahani; M Romero Perez; I Lobysheva; O Devuyst; C Dessy; J L Balligand
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

9.  β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure.

Authors:  Satoshi Masutani; Heng-Jie Cheng; Atsushi Morimoto; Hiroshi Hasegawa; Qing-Hua Han; William C Little; Che Ping Cheng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

10.  Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes.

Authors:  Peng Zhao; Subat Turdi; Feng Dong; Xiaoyan Xiao; Guohai Su; Xinglei Zhu; Glenda I Scott; Jun Ren
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.